BioScrip, Inc. · Elmsford, NY United States (NASDAQ: BIOS)
Key BioScrip, Inc. Financials
| Company Type | Public -(NASDAQ: BIOS) Headquarters |
|---|---|
| Fiscal Year-End | April |
| 2010 Sales (mil.) | $1,638.6 |
| 2010 Employees | 3,475 |
BioScrip, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 1,638.6 | 1,329.5 | 1,401.9 |
| Cost of Goods Sold | 1,378.2 | 1,171.7 | 1,259.7 |
| Gross Profit | 260.4 | 157.8 | 142.2 |
| Gross Profit Margin | 15.9% | 11.9% | 10.1% |
| SG&A Expense | 210.9 | 133.7 | 129.9 |
| Depreciation & Amortization | 3.8 | 0.0 | 1.9 |
| Operating Income | 15.8 | 15.5 | (83.5) |
| Operating Margin | 1% | 1.2% | -6% |
| Nonoperating Income | (9.6) | 0.0 | (93.9) |
| Nonoperating Expenses | (27.6) | (1.9) | -- |
| Income Before Taxes | (21.4) | 13.5 | (86.2) |
| Income Taxes | 47.7 | (40.6) | (12.2) |
| Net Income After Taxes | (69.1) | 54.1 | (74.0) |
| Continuing Operations | (69.1) | 54.1 | (74.0) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (69.1) | 54.1 | (74.0) |
| Total Net Income | (69.1) | 54.1 | (74.0) |
| Net Profit Margin | -4.2% | 4.1% | -5.3% |
| Diluted EPS from Total Net Income | (1.37) | 1.36 | (1.93) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
BioScrip, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 0.0 | 0.0 | -- |
| Net Receivables | 193.7 | 151.1 | 158.6 |
| Inventories | 66.5 | 51.3 | 45.2 |
| Other Current Assets | 16.7 | 16.9 | 2.8 |
| Total Current Assets | 276.9 | 219.3 | 206.6 |
| Net Fixed Assets | 23.9 | 15.5 | 14.7 |
| Other Noncurrent Assets | 363.1 | 52.5 | 25.6 |
| Total Assets | 664.0 | 287.2 | 247.0 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 80.8 | 74.5 | 76.9 |
| Short-Term Debt | 81.4 | 30.4 | 50.4 |
| Other Current Liabilities | 64.6 | 23.3 | 20.5 |
| Total Current Liabilities | 226.8 | 128.2 | 147.8 |
| Long-Term Debt | 225.1 | 2.4 | -- |
| Other Noncurrent Liabilities | 12.0 | 0.8 | 3.6 |
| Total Liabilities | 463.9 | 131.4 | 151.4 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | -- |
| Common Stock Equity | 200.1 | 155.8 | 95.5 |
| Total Equity | 200.1 | 155.8 | 95.5 |
| Shares Outstanding (thou.) | 54,118.5 | 39,675.9 | 38,680.4 |
All amounts in millions of US Dollars except per share amounts.
BioScrip, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | (21) | 23 | (9) |
| Net Investing Cash Flow | (108.5) | (5.7) | (7.5) |
| Net Financing Cash Flow | 130.0 | (17.0) | 16.2 |
| Net Change in Cash | 0.0 | 0.0 | 0.0 |
| Depreciation & Amortization | 3.8 | 0.0 | 1.9 |
| Capital Expenditures | (11.1) | (5.7) | (7.5) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.